Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus–related liver carcinogenesis

Translational Research

Volumn 168, Issue , 2016, Pages 122-133

  Piciocchi, Marika ^a   Cardin, Romilda ^a   Cillo, Umberto ^a   Vitale, Alessandro ^a   Cappon, Andrea ^b   Mescoli, Claudia ^a   Guido, Maria ^a   Rugge, Massimo ^a   Burra, Patrizia ^a   Floreani, Annarosa ^a   Farinati, Fabio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DEOXYGUANOSINE; GENOMIC DNA; MITOCHONDRIAL DNA; TELOMERASE; 8-OXO-7-HYDRODEOXYGUANOSINE; DNA GLYCOSYLTRANSFERASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; TERT PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DNA DAMAGE; DNA METHYLATION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE; GENE LOCATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; OGG1 GENE; OXIDATIVE STRESS; PATIENT; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TELOMERE SHORTENING; ANALOGS AND DERIVATIVES; CARCINOGENESIS; COMPLICATION; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; HEPACIVIRUS; LIVER NEOPLASMS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; VIROLOGY;

CARCINOGENESIS; DEOXYGUANOSINE; DNA DAMAGE; DNA GLYCOSYLASES; DNA, MITOCHONDRIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; OXIDATION-REDUCTION; POLYMORPHISM, GENETIC; TELOMERASE; TELOMERE SHORTENING;

EID: 84945892364     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.08.012     Document Type: Article

References (46)

1. 1 Allavena, P., Mantovani, A., Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clin Exp Immunol 167 (2012), 195–205.
2. 2 Mantovani, A., Molecular pathways linking inflammation and cancer. Curr Mol Med 10 (2010), 369–373.
3. 3 Aravalli, R.N., Cressman, E.N., Steer, C.J., Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch Toxicol 87 (2013), 227–247.
4. 4 Fujita, N., Sugimoto, R., Ma, N., et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat 15 (2008), 498–507.
5. 5 Klaunig, J.E., Kamendulis, L.M., Hocevar, B.A., Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38 (2010), 96–109.
6. 6 Kohno, T., Shinmura, K., Tosaka, M., et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16 (1998), 3219–3225.
7. 7 Oikawa, S., Kawanishi, S., Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 453 (1999), 365–368.
8. 8 Iliopoulos, D., Satra, M., Drakaki, A., Poultsides, G.A., Tsezou, A., Epigenetic regulation of hTERT promoter in hepatocellular carcinomas. Int J Oncol 34 (2009), 391–399.
9. 9 Maser, R.S., DePinho, R.A., Connecting chromosomes, crisis, and cancer. Science 297 (2002), 565–569.
10. 10 Edmondson, H.A., Steiner, P.E., Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954), 462–503.
11. 11 Bruix, J., Sherman, M., Llovet, J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001), 421–430.
12. 12 Omata, M., Lesmana, L.A., Tateishi, R., et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4 (2010), 439–474.
13. 13 Knodell, R.G., Ishak, K.G., Black, W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 (1981), 431–435.
14. 14 Brunt, E.M., Janney, C.G., Di Bisceglie, A.M., Neuschwander-Tetri, B.A., Bacon, B.R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999), 2467–2474.
15. 15 Cardin, R., Piciocchi, M., Sinigallia, A., et al. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer, 12, 2012, 177 (in Pubmed the Authors’ names are mistakenly reported as Romilda C, Marika P, Alessandro S, Enrico L, Marina B, Andromachi K, et al.).
16. 16 Cawthon, R.M., Telomere measurement by quantitative PCR. Nucleic Acids Res, 30, 2002, e47.
17. 17 Guilleret, I., Benhattar, J., Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem Biophys Res Commun 325 (2004), 1037–1043.
18. 18 Dimauro, I., Pearson, T., Caporossi, D., Jackson, M.J., A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res Notes, 5, 2012, 513.
19. 19 Cardin, R., Saccoccio, G., Masutti, F., Bellentani, S., Farinati, F., Tiribelli, C., DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 34 (2001), 587–592.
20. 20 Raimondi, S., Bruno, S., Mondelli, M.U., Maisonneuve, P., Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 50 (2009), 1142–1154.
21. 21 Shan, Y.S., Hsieh, Y.H., Lin, P.W., Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection. World J Surg 31 (2007), 1121–1128.
22. 22 Moriya, K., Nakagawa, K., Santa, T., et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61 (2001), 4365–4370.
23. 23 Toh, S.T., Jin, Y., Liu, L., et al. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. Carcinogenesis 34 (2013), 787–798.
24. 24 Ding, D., Lou, X., Hua, D., et al. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet, 8, 2012, e1003065.
25. 25 Paterlini-Bréchot, P., Saigo, K., Murakami, Y., et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22 (2003), 3911–3916.
26. 26 Guerrieri, F., Belloni, L., Pediconi, N., Levrero, M., Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 33 (2013), 147–156.
27. 27 Arzumanyan, A., Reis, H.M., Feitelson, M.A., Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer 13 (2013), 123–135.
28. 28 Bouchard, M.J., Navas-Martin, S., Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett 305 (2011), 123–143.
29. 29 Gearhart, T.L., Bouchard, M.J., The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes. Virus Res 155 (2011), 363–367.
30. 30 El Idrissi, M., Hervieu, V., Merle, P., Mortreux, F., Wattel, E., Cause-specific telomere factors deregulation in hepatocellular carcinoma. J Exp Clin Cancer Res, 32, 2013, 64.
31. 31 Sekoguchi, S., Nakajima, T., Moriguchi, M., et al. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C. J Gastroenterol Hepatol 22 (2007), 182–190.
32. 32 Houben, J.M., Moonen, H.J., van Schooten, F.J., Hageman, G.J., Telomere length assessment: biomarker of chronic oxidative stress?. Free Radic Biol Med 44 (2008), 235–246.
33. 33 Oh, B.K., Kim, H., Park, Y.N., et al. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 88 (2008), 144–152.
34. 34 Saini, N., Srinivasan, R., Chawla, Y., Sharma, S., Chakraborti, A., Rajwanshi, A., Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int 29 (2009), 1162–1170.
35. 35 Miura, N., Horikawa, I., Nishimoto, A., et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 93 (1997), 56–62.
36. 36 Lambert, M.P., Paliwal, A., Vaissière, T., et al. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake. J Hepatol 54 (2011), 705–715.
37. 37 Ozen, C., Yildiz, G., Dagcan, A.T., et al. Genetics and epigenetics of liver cancer. N Biotechnol 30 (2013), 381–384.
38. 38 Zhu, J., Zhao, Y., Wang, S., Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell 1 (2010), 22–32.
39. 39 Jakob, S., Schroeder, P., Lukosz, M., et al. Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase. J Biol Chem 283 (2008), 33155–33161.
40. 40 Buchner, N., Zschauer, T.-C., Lukosz, M., Altschmied, J., Haendeler, J., Downregulation of mitochondrial telomerase reverse transcriptase induced by H2O2 is Src kinase dependent. Exp Gerontol 45 (2010), 558–562.
41. 41 Santos, J.H., Meyer, J.N., Van Houten, B., Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15 (2006), 1757–1768.
42. 42 Indran, I.R., Hande, M.P., Pervaiz, S., hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res 71 (2011), 266–276.
43. 43 Haendeler, J., Dröse, S., Büchner, N., et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 29 (2009), 929–935.
44. 44 Nomoto, K., Tsuneyama, K., Takahashi, H., Murai, Y., Takano, Y., Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in Nonalcoholic fatty liver disease. Appl Immunohistochem Mol Morphol 16 (2008), 71–75.
45. 45 Ralph, S.J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E., Moreno-Sánchez, R., The causes of cancer revisited: “mitochondrial malignancy” and ROS-induced oncogenic transformation—why mitochondria are targets for cancer therapy. Mol Aspects Med 31 (2010), 145–170.
46. 46 Tauskela, J.S., MitoQ–a mitochondria-targeted antioxidant. Drugs 10 (2007), 399–412.